First Time Loading...

Medigene AG
XETRA:MDG1

Watchlist Manager
Medigene AG Logo
Medigene AG
XETRA:MDG1
Watchlist
Price: 1.505 EUR -5.64% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

MDG1 Price Targets Summary
Medigene AG

Wall Street analysts forecast MDG1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDG1 is 2.729 EUR with a low forecast of 2.374 EUR and a high forecast of 3.15 EUR.

MDG1 Lowest Forecast
Wall Street Target
2.374 EUR
58% Upside
MDG1 Average Forecast
Wall Street Target
2.729 EUR
81% Upside
MDG1 Highest Forecast
Wall Street Target
3.15 EUR
109% Upside
Lowest
Price Target
2.374 EUR
58% Upside
Average
Price Target
2.729 EUR
81% Upside
Highest
Price Target
3.15 EUR
109% Upside
Medigene AG Competitors:
Price Targets
G
144510
GC Cell Corp
97% Upside
INCY
Incyte Corp
49% Upside
IOVA
Iovance Biotherapeutics Inc
128% Upside
068270
Celltrion Inc
34% Upside
G
144510
GC Cell Corp
97% Upside
INCY
Incyte Corp
49% Upside
IOVA
Iovance Biotherapeutics Inc
128% Upside
068270
Celltrion Inc
34% Upside
P
214450
PharmaResearch Co Ltd
47% Upside
E
1952
Everest Medicines Ltd
3% Upside
A
298380
ABL Bio Inc
46% Upside
OCC
Orthocell Ltd
50% Upside

Revenue
Forecast

Revenue Estimate
Medigene AG

For the last 8 years the compound annual growth rate for Medigene AG's revenue is 11%. The projected CAGR for the next 4 years is -15%.

11%
Past Growth
-15%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medigene AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medigene AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
MDG1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDG1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDG1 stock valuation using valuation multiples.
Wall Street Estimates
MDG1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDG1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDG1's stock price target?
Price Target
2.729 EUR

According to Wall Street analysts, the average 1-year price target for MDG1 is 2.729 EUR with a low forecast of 2.374 EUR and a high forecast of 3.15 EUR.

What is Medigene AG's Revenue forecast?
Projected CAGR
-15%

For the last 8 years the compound annual growth rate for Medigene AG's revenue is 11%. The projected CAGR for the next 4 years is -15%.

ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.